-
Healthcare AI market worth $10bn plus by 2024 – report
pharmaphorum
April 16, 2018
The healthcare artificial intelligence (AI) market is to exceed $10 billion by 2024, according to a new report.
-
Mitsubishi and Hitachi to use AI to hasten drug R&D
pharmaphorum
March 27, 2018
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.
-
Insilico Medicine Starts Asia's First AI R&D Base in Taiwan, China
biospectrumasia
March 26, 2018
The companies will form an alliance with the Center for Biotechnology, the Institute for Information Industry, and TUL Corporation to implement the "AI Digital Health Talent Development Project
-
AI Singapore signs MoU with Intel
biospectrumasia
March 16, 2018
A goal has been set for engaging and training around 2000 students and developers over the next three years.
-
Johns Hopkins Study Reveals Artificial Intelligence (AI)-Driven Mobile App Sweetch Reduces Blood Sug
biospace
March 09, 2018
Sweetch, the mobile-health app that helps prevent and improve outcomes in diabetes by encouraging long-term behavioral change, today revealed the outcomes of its clinical trial conducted at Johns Hopkins University
-
Microsoft partnered with Apollo to create an AI system in cardiology
biospectrumasia
March 09, 2018
This is part of Microsoft Healthcare NExT to accelerate innovation through artificial intelligence and cloud computing
-
AI and facial diagnosis company FDNA sets up genomics coalition
fiercebiotech
March 01, 2018
Boston biotech FDNA has teamed up with several research organizations to create a consortium that will try to apply artificial intelligence and machine learning to the development of new medicines—and it's looking for other partners.
-
HKSTP to focus on biotech, AI to drive innovation
biospectrumasia
March 01, 2018
The goal is to turn Hong Kong, S.A.R., China into a top-notch biotech quality-testing center in the region.
-
China AI biotech XtalPi lands $15M from Sequoia, Google, Tencent
fiercebiotech
January 26, 2018
As capital continues to pile onto applications of artificial intelligence in drug R&D, XtalPi, a Chinese startup working in that field, has secured a $15 million series B backed by high-profile tech investors Sequoia China, Google and Chinese internet gia
-
Seegene develops world's first multiplex MDx assays with its AI system
prnasia
January 04, 2018
sensitivity and specificity) of the assays developed by AI are equivalent to or even better than that of those manually developed," and also added, "Only four (4) days were sufficient by the AI system to successfully develop two 8-plex assays